EPOTREND 6000 IU INJECTION

Epotrend 6000 IU injection is a potent combination of components like Recombinant Human erythropoietin and epoetin. It is a medication that belongs to a class of drugs called erythropoiesis-stimulating agents (ESAs). The medication is used to treat anaemia that is due to chronic kidney diseases (CKD), as well as chemotherapy for cancer or HIV treatment using zidovudine. It also reduces the requirement for transfusions of red blood cells for patients at risk of blood loss as a result of surgery planned and other surgical procedures.
Epotrend 6000 IU injections should not be administered to patients suffering from uncontrolled hypertension or hypersensitivity active thrombotic microangiopathy (TMA) and purified red cell aplasia (PRCA) and seizures that are not controlled and pregnancy or lactation. Also, it should be used carefully in patients who have a previous history of blood clots, heart disease, kidney disease, stroke, atherosclerosis, liver damage, sickle-cell anaemia, myelodysplastic disorder, leukaemia or cancer. It should not be used for children under 18 when the benefits outweigh the risks. Older adults taking this medication must be monitored closely for adverse reactions. Before beginning this medication, you must consult your physician about the potential risks and advantages of Epotrend 6000 IU injection.